VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVCR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVCRNovoCure Limited
$17.72$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNVCRPrice History

NVCR logoNovoCure Limited (NVCR) Stock Price History

Historical prices from 2015 to 2026

$17.72+0.40  (+2.31%)close Jul 7
Returns
1M
+5.2%
3M
+71.2%
YTD
+35.1%
1Y
+4.9%
3Y
-24.4%
5Y
-37.5%
ATH$232.76Jun 2021-92.4%
ATL$5.95Nov 2016pre-split
Avg Vol (50D)1.6M/ day
52-Week Range$9.82 — $18.92
LowCurrent: $17.72High

Loading 10-year price history...

NVCR Historical Performance

1 YearTotal Return
+4.9%
Price: +4.9%
3 YearsTotal Return
-56.9%
CAGR: -24.4%
Price: -56.9%
5 YearsTotal Return
-90.5%
CAGR: -37.5%
Price: -90.5%
YTD
+35.1%

NVCR Annual Returns

Year-by-year price performance · 2015–2026

Best+157.5%2019
Worst-78.0%2023
Up years7/12
2015+1.6%
2016-65.2%
2017+157.3%
2018+64.9%
2019+157.5%
2020+125.1%
2021-53.5%
2022-8.4%
2023-78.0%
2024+106.9%
2025-56.9%
2026+4.2%
2015 annual price return
+1.6%
2016 annual price return
-65.2%
2017 annual price return
+157.3%
2018 annual price return
+64.9%
2019 annual price return
+157.5%
2020 annual price return
+125.1%
2021 annual price return
-53.5%
2022 annual price return
-8.4%
2023 annual price return
-78.0%
2024 annual price return
+106.9%
2025 annual price return
-56.9%
2026 annual price return
+4.2%
LessMore
Alpha vs S&P 500
1Y-34.3%
3Y-49.7%
5Y-54.1%

Price returns only.

Download Historical Data

2,706 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NVCR Stock Price Trajectory (2015–2026)

As of July 8, 2026, NovoCure Limited (NVCR) trades at $17.72, representing a +4.9% return over the past year. The stock has delivered a -90.5% total return over five years (-37.5% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $232.76 on June 24, 2021. From this peak, NVCR has corrected -92.4%, currently trading 31% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers NKTR (+219.1% 1Y), INVA (+17.7% 1Y), and SUPN (+50.7% 1Y), NVCR has underperformed the peer group average. Compare NVCR vs NKTR →

NVCR Historical Price Data · from 2015

Rows 1–50 of 2,706
Date Open High Low Close Volume Change %
2026-07-0717.1317.7616.6417.721.04M+2.31%
2026-07-0617.0017.8016.8017.321.64M+0.70%
2026-07-0215.8717.3115.6117.201.88M+9.00%
2026-07-0115.3716.0015.2915.781.17M+4.16%
2026-06-3015.4715.6014.9615.151.35M-2.13%
2026-06-2915.4215.6015.1415.48995K+0.32%
2026-06-2614.9715.6314.9015.430+2.52%
2026-06-2514.7115.1314.6315.051.20M+2.24%
2026-06-2414.2915.1114.1714.721.45M+4.18%
2026-06-2313.4414.3213.4414.131.69M+3.82%
2026-06-2214.3114.5113.5213.611.92M-4.69%
2026-06-1814.9015.1013.9414.284.50M-20.00%
2026-06-1717.5318.0017.3617.851.22M+2.06%
2026-06-1617.6017.9017.4517.49868K-0.63%
2026-06-1518.3218.3517.4817.601.22M-1.01%
2026-06-1217.6218.0517.2517.78990K+0.40%
2026-06-1116.8017.7316.4117.711.32M+6.37%
2026-06-1017.0917.5416.6316.65952K-3.42%
2026-06-0917.0717.6616.9817.241.38M+2.31%
2026-06-0817.2617.9116.8416.851.16M-1.81%
2026-06-0517.6717.9217.0317.161.60M-4.61%
2026-06-0416.2318.3916.2317.992.22M+11.39%
2026-06-0315.6416.1714.8516.151.65M+2.09%
2026-06-0216.4816.4815.6515.821.29M-4.47%
2026-06-0116.9317.7916.4916.561.43M-2.82%
2026-05-2917.2217.3416.8617.041.25M-1.22%
2026-05-2816.9417.5516.6717.251.16M+1.53%
2026-05-2718.2618.3416.7816.991.41M-6.96%
2026-05-2618.0018.6717.8018.261.78M+1.67%
2026-05-2217.9818.1717.7817.96801K+0.34%
2026-05-2117.5018.1717.3317.901.10M+0.85%
2026-05-2017.1017.8716.8617.751.27M+4.35%
2026-05-1917.4217.5317.0017.01911K-2.58%
2026-05-1817.7618.4017.3517.461.71M-0.68%
2026-05-1517.8218.2517.4417.581.41M-2.60%
2026-05-1418.1318.4317.8218.051.50M-0.28%
2026-05-1318.1218.5017.8418.101.06M-1.15%
2026-05-1218.1118.5117.7018.311.38M+1.16%
2026-05-1118.4818.9217.8518.102.58M+1.17%
2026-05-0816.9018.1916.8517.892.30M+6.30%
2026-05-0716.6117.2116.1316.831.46M+2.03%
2026-05-0615.9016.7415.4016.501.47M+3.87%
2026-05-0516.5616.7615.7915.881.93M-6.20%
2026-05-0416.4317.2216.3416.933.02M+1.87%
2026-05-0115.4316.7015.3516.623.53M+9.27%
2026-04-3013.3015.5213.3015.217.13M+27.49%
2026-04-2911.9012.0011.6111.931.07M-1.57%
2026-04-2812.3812.6512.0812.12870K-2.88%
2026-04-2712.4112.7012.3212.48869K+0.08%
2026-04-2412.6912.7612.3212.47647K-0.95%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NVCR — Frequently Asked Questions

Quick answers to the most common questions about buying NVCR stock.

How has NVCR stock performed recently?

NVCR returned +4.9% over the past year, beating its 5-year annualized CAGR of -37.5%. The stock trades above its 200-day moving average, confirming the uptrend.

What is NVCR's all-time high price?

NovoCure Limited reached $232.76 on 2021-06-24. The 52-week high is $18.92. Current 1-year return of +4.9% places the stock closer to historical peaks.

Where can I download NVCR historical price data?

This page provides NVCR daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.

452 data points · sampled from 2,706